Article
Protein domains of APOL1 and its risk variants.
Experimental and molecular pathology - 1 Aug 2015
Lan Xiqian, Wen Hongxiu, Lederman Rivka, Malhotra Ashwani, Mikulak Joanna, Popik Waldemar, Skorecki Karl, Singhal Pravin C
Abstract excerpt
Increasing lines of evidence have demonstrated that the development of higher rates of non-diabetic glomerulosclerosis (GS) in African Americans can be attributed to two coding sequence variants (G1 and G2) in the Apolipoprotein L1 (APOL) gene. Recent studies indicate that the gene products of these APOL1 risk variants have augmented toxicity to kidney cells. However, the biological characteristics of APOL1 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
